About this trial
The objectif is to study the diagnosis performance of the different classification criteria in reference to the gold standard consisting of the diagnosis made by expert doctors after standardized assessment, of pSS (primary Sjogren syndrome)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Major patient
Suspicion of SSp (clinical or biological criteria, i.e. dry eye or oral syndrome, arthritis, parotidomegaly, neuropathy, kidney or lung disease...)
Patient affiliated with Social Security
Patient who has signed written informed consent
Disqualifiers
Refusal to participate
Pregnant and lactating woman
Trial design
Parallel
Treatments tested in this trial
Blood, fluid, sells and urine samples
Other interventionBlood, fluid, sells and urine samples will be collected.
Treatment groups
Trial outcomes
Primary outcomes
Description specificity of different classification criteria FOR sJOGREN (EULAR/ACR 2019, european criteria)
Specificity of different classification criteria, the standard gold being the diagnosis obtained by consensus of expert doctors after standardized assessment.
Secondary outcomes
Number of patients with different manifestation including in the ESSDAI (Eular Sjögren Syndrome Disease Activity index), gold standard to measure
number of patients wit arthritis of more than 6 joints, parotidomegaly, intertitial lung disease
Number of patients with rheumatological manifestations
number of patients wit arthritis of more than 6 joints, parotidomegaly, intertitial lung disease
Number of patients with dermatological manifestations
number of patients wit arthritis of more than 6 joints, parotidomegaly, intertitial lung disease
Description diagnostic performance of new tests
after evaluation of all différents test performed added to the classical items of the ACR 2017: ie ultrasound parenchymal abnormalities, sub population of B cells....
Sponsors and contacts
Click on the lead sponsor to view all of their trials.